Vitol Holding’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Hold
40,000
100% 1
2025
Q4
$10.9M Hold
40,000
100% 1
2025
Q3
$10.8M Hold
40,000
74.69% 1
2025
Q2
$11M Hold
40,000
80.06% 1
2025
Q1
$10.6M Hold
40,000
83.27% 1
2024
Q4
$9.29M Hold
40,000
70.58% 1
2024
Q3
$8.83M Hold
40,000
74.62% 1
2024
Q2
$7.86M Hold
40,000
71.7% 1
2024
Q1
$8.61M Hold
40,000
72.21% 1
2023
Q4
$8.42M Hold
40,000
84.68% 1
2023
Q3
$8.01M Hold
40,000
89.79% 1
2023
Q2
$7.41M Hold
40,000
100% 1
2023
Q1
$7.66M Hold
40,000
100% 1
2022
Q4
$6.73M Hold
40,000
100% 1
2022
Q3
$7.09M Hold
40,000
100% 1
2022
Q2
$8.19M Hold
40,000
100% 1
2022
Q1
$9.51M Hold
40,000
100% 1
2021
Q4
$9.14M Hold
40,000
100% 1
2021
Q3
$7.74M Hold
40,000
100% 1
2021
Q2
$8.51M Hold
40,000
100% 1
2021
Q1
$8.17M Hold
40,000
100% 1
2020
Q4
$7.28M Hold
40,000
100% 1
2020
Q3
$6.69M Buy
+40,000
New +$6.74M 100% 1

Other funds holding CME

Vitol Holding's CME Position: Q1 2026 in Review

Vitol Holding held its CME Group (CME) position steady in Q1 2026 at 40,000 shares worth $11.9M. The position accounts for 100% of the portfolio, ranked #1.

Vitol Holding first reported a position in CME in Q3 2020 and has held it in 23 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Vitol Holding held 40,000 shares of CME Group worth $11.9M as of Q1 2026.
  • Vitol Holding left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 100% of Vitol Holding's portfolio in Q1 2026, its #1 holding.
  • Vitol Holding first reported a position in CME Group in Q3 2020 and has held it in 23 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Vitol Holding's 13F filing for Q1 2026, filed 13 May 2026.